ICON.L

Iconic Labs Plc
Iconic Labs PLC - Notice of AGM
19th January 2024, 15:49
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 3408A
Iconic Labs PLC
19 January 2024
 

19 January 2024

 

Iconic Labs PLC

 

("Iconic" or the "Company")

 

Notice of AGM

 

Iconic Labs PLC (LSE: ICON) announces that its Annual General Meeting ('AGM') will be held on Tuesday, 13 February 2024 at 12 noon at the offices of RWK Goodman, 69 Carter Lane, London, EC4V 5EQ.

 

The Notice of AGM has been posted to Shareholders and will be available to view shortly on the Company's website at: https://www.iconiclabs.co.uk/documents/.

 

Amongst others, a special resolution at the AGM will be proposed seeking the approval of Shareholders to a share capital reorganisation.

 

For some time, the shares of the Company have been trading at below nominal value of £0.10. The issue of new ordinary shares in the Company at a price which is less than nominal value is prohibited by the UK Companies Act. The Board, therefore, considers it prudent to seek the approval of shareholders to a sub-division and conversion of each existing ordinary share of £0.10 ("Existing Ordinary Shares") into one new ordinary share of £0.0001  (a "New Ordinary Share") and one deferred share of £0.0999 (a "Deferred Share") (each such Deferred Share having no voting or dividend rights and effectively being worthless) in order that the nominal value of a New Ordinary Share is less than the price of a share in the market. This will enable the Company to raise funds in the future by issuing further shares, should the Directors elect to do so. By effecting this share capital reorganisation in this way, the Company's issued share capital remains the same and similarly, the nominal value of a Shareholder's shareholding will remain unchanged.

 

EXPECTED TIMETABLE OF PRINCIPAL EVENTS

 

 

 

 

Publication and posting of the AGM Notice

19 January 2024

Latest time and date for receipt by Registrars of Form of Proxy  in respect of the Annual General Meeting

12 noon on 9 February 2024

Annual General Meeting

12 noon on 13 February 2024

Record Date for the Share Capital Reorganisation

6.00 pm on 13 February 2024

Effective Date for the Share Capital Reorganisation

8.00 am on 14 February 2024

 

- Ends -

 

For more information, please contact:

Iconic Labs

 

Brad Taylor, Chief Executive Officer

Tel: +44 (0) 7462 156238

Novum Securities Limited

David Coffman / Daniel Harris

Tel: +44 (0) 20 7399 9400

 

Yellow Jersey PR

Sarah Hollins

Annabelle Wills

Bessie Elliot

 

Tel: +44 (0) 20 3004 9512

iconic@yellowjerseypr.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAGPUMGGUPCGWB]]>
TwitterFacebookLinkedIn